SGLT2 inhibitors have been shown to reduce risk of acute kidney injury, but whether kidney effects are modified by risk of acute dips in eGFR is unknown.

Increased mortality seen in association with longer nap duration, greater intraindividual variability, more naps from 11 a.m. to 1 p.m., 1 to 3 p.m.